How Is Huntington’s Disease Diagnosed?

How Is Huntington's Disease Diagnosed?

Key Takeaways

  • Genetic testing is the definitive diagnostic tool to identify the gene that causes Huntington’s disease, and you can have the genetic test years before symptoms begin.
  • Huntington’s disease stage and progression is determined by a clinical assessment of symptoms, brain imaging, and tests to detect complications.
  • Emerging tests can help determine disease progression and treatment responses. 

Huntington’s disease is diagnosed based on genetic testing and an evaluation of clinical symptoms. Other diagnostic studies that may help in evaluating disease progression include brain imaging and disease staging rating scales.

Genetic testing is used to diagnose Huntington’s disease, and brain scans are used in staging.

TEK IMAGE/SCIENCE PHOTO LIBRARY / Getty Images


Clinical Assessment 

If you have symptoms of Huntington’s disease or any neurological symptoms, it’s crucial for you to see a healthcare provider. 

A clinical diagnosis of Huntington’s disease is based on:

  • A review of your symptoms, the timing, and the progression
  • A physical examination, which will include assessment of your reflexes, walking, muscle tone, coordination, muscle strength, and speech
  • Consideration of other medical conditions that could be causing your symptoms

It’s possible for a person to be the first in their family to experience Huntington’s disease, especially if parents or grandparents died before the symptoms developed, or without an accurate diagnosis.

Genetic Testing

A genetic blood test can identify whether you have the gene that causes Huntington’s disease. If you have inherited the gene that causes this disease, you will develop Huntington’s disease, and if you do not have the gene that causes the disease, you will not develop the condition.

Huntington’s disease usually begins to cause symptoms in middle age. There is a form of Huntington’s disease defined as juvenile onset, where people begin to experience symptoms earlier. 

Individuals who have a known family history of Huntington’s disease may opt to have a genetic test at any age. If you have a known family history of Huntington’s disease, the decision to have a blood test requires a lot of thought, because:

  • If you have the gene, each child you have has a 50% chance of inheriting the gene.
  • Knowing that you will develop the disease can lead to depression.
  • You might make major life decisions based on the outcome of the test.
  • Huntington’s disease usually causes early death.
  • Siblings may have strained relationships if some siblings inherit the gene, and others do not.

You could consider speaking with a genetic counselor as you make your decision about getting tested.

Disease Stage 

If you’ve been diagnosed with Huntington’s disease, your medical team may track your condition using measures such as:

  • Huntington’s Disease Integrated Staging System (HD-ISS)
  • Total Functional Capacity (TFC) scale
  • Adult Functional Adaptive Behavior (AFAB) scale

These scales provide consistency for your health care team to use to define your Huntington’s disease progression, with benchmarks for cognitive and physical abilities.

Brain Imaging

Brain imaging studies, including magnetic resonance imaging (MRI) and positron emission tomography (PET), can identify patterns consistent with Huntington’s disease.

Imaging can be used as a supplement to your diagnostic process by identifying atrophy (shrinking) and damage to brain cells in different areas of the brain.

You Can Also Develop Unrelated Medical Conditions

It’s important for a person with the gene for Huntington’s disease to know they can also experience illnesses unrelated to Huntington’s disease.

For example, a person who carries the gene for Huntington’s disease could develop muscle weakness or clumsiness due to causes other than Huntington’s disease, such as a pinched nerve or an infection. It’s beneficial to get an accurate diagnosis because these other conditions can be treated.

Surveillance for Complications 

If you’re living with Huntington’s disease, you need ongoing medical care so complications can be detected any early stage.

Monitoring may include:

  • Periodic assessment of your swallowing abilities
  • Medical attention if you develop a fever or any signs of an infection
  • Screening for symptoms of depression
  • Testing of your cognitive abilities (thinking and problem-solving skills)
  • Screening for thought disorders, such as hallucinations or delusions

Your medical team will look for signs of illness, worsening disability, and disease progression, so you can receive adequate treatment to reduce the risk of life-threatening health complications.

Emerging Tests 

Several emerging tests are being examined in research settings to develop markers for Huntington’s disease, including blood protein markers and imaging tools. These tests may improve the staging process and help develop new treatments and evaluate treatment effectiveness.

Verywell Health uses only high-quality sources, including peer-reviewed studies, to support the facts within our articles. Read our editorial process to learn more about how we fact-check and keep our content accurate, reliable, and trustworthy.
  1. Szabó G, Szegedi M, Bálint S, et al. A premotoros szakaszban szkizofreniform pszichózissal és narcolepsiával jelentkező Huntington-kór esete [Huntington’s disease presenting with schizophreniform psychosis and narcolepsy in the premotor phase]. Orv Hetil. 2025;166(52):2064-2072. doi:10.1556/650.2025.33430

  2. National Institute of Neurological Disorders and Stroke. Huntington’s disease.

  3. Aatli A, Saryan S, Sehgal R, Kashyap A, Gupta A. Navigating the uncommon: “juvenile-onset Huntington disease“. J Child Neurol. Published online December 19, 2025. doi:10.1177/08830738251396171

  4. Knights H, Coleman A, Farag M, et al. Bias in HD-ISS staging introduced by the FreeSurfer cross-sectional stream: Insights from the Huntington’s Disease Young Adult Study (HD-YAS). J Huntingtons Dis. 2025;14(4):396-402. doi:10.1177/18796397251366900

  5. Heim B, Krismer F, Hemicker G, et al. Simple diameters, accurate stages:a practical approach to HD-ISS staging. J Neurol. 2025;272(12):760. doi:10.1007/s00415-025-13409-1

  6. Wang X, Li Y, Li B, Shang H, Yang J. Gray matter alterations in Huntington’s disease: a meta-analysis of VBM neuroimaging studies. J Neurosci Res. 2024;102(7):e25366. doi:10.1002/jnr.25366

  7. Roiboit CM, Mammen JR, Adams JL, Stout JC. Do cognitive tests capture symptoms that matter to people with Huntington’s disease?. Sci Rep. 2025;15(1):43609. doi:10.1038/s41598-025-27147-x

  8. Konvalinkova R, Srp M, Doleckova K, et al. Handgrip strength and the Index of pulmonary dysfunction: Practical screening tools for cough dysfunction in huntington’s disease. J Huntingtons Dis. Published online October 14, 2025. doi:10.1177/18796397251385607

  9. Chelsky D, Joyce C, Bockholt HJ, et al. Discovery and targeted proteomic studies reveal striatal markers validated for Huntington’s disease. Ann Clin Transl Neurol. Published online December 9, 2025. doi:10.1002/acn3.70272

  10. Zajicek F, Everix L, Van Eetveldt A, et al. Preclinical evaluation of [11C]CHDI-009R for quantification of mutant huntingtin aggregates. J Mol Med (Berl). 2025;104(1):7. doi:10.1007/s00109-025-02621-1

Heidi Moawad, MD

By Heidi Moawad, MD

Dr. Moawad is a neurologist and expert in brain health. She regularly writes and edits health content for medical books and publications.